Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase Study. [PDF]
Kim DH +6 more
europepmc +1 more source
Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients [PDF]
core +1 more source
Safety and effectiveness of apixaban use for stroke prevention during Ramadan fasting (the API-RAM study). [PDF]
Ghrab A +14 more
europepmc +1 more source
Assessment of the Anticoagulation Activity of Apixaban – Reply –
Johanne Silvain
openalex +2 more sources
Comparative analysis of apixaban vs. enoxaparin for thromboprophylaxis after radical cystectomy A single-center, observational, before-after study. [PDF]
Macklin CS +5 more
europepmc +1 more source
VALIDATION OF THE APIXABAN COST-EFFECTIVENESS MODEL IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Tereza Lanitis +7 more
openalex +1 more source
Serum Concentration of Apixaban in Relation to Renal Function in Older Hospitalized Patients. [PDF]
Mellingsæter TC, Molden E, Steihaug OM.
europepmc +1 more source
New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities [PDF]
core +1 more source
MRI findings intracranial hemorrhages in ARCADIA-MRI: an ancillary study to the ARCADIA trial. [PDF]
Chen H +15 more
europepmc +1 more source

